Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B

BACKGROUND AND OBJECTIVES: Hsa-miR-429 is increased in bladder cancer. Its roles in bladder cancer are poorly understood. METHODS: The expression levels of hsa-miR-429 and cyclin-dependent kinase inhibitor 2B (CDKN2B) were determined using Real-Time qPCR in a total of 50 patients with bladder cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiangeng, Liu, Yuchen, He, Anbang, Liu, Yuhan, Wu, Jianting, Liao, Xinhui, Lv, Zhaojie, Wang, Feng, Mei, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620291/
https://www.ncbi.nlm.nih.gov/pubmed/28978151
http://dx.doi.org/10.18632/oncotarget.19878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620291/
https://www.ncbi.nlm.nih.gov/pubmed/28978151
http://dx.doi.org/10.18632/oncotarget.19878

Ejemplares similares